Small Molecules
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
539
NCT03331770
Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost
Phase: Phase 4
Role: Lead Sponsor
Start: Jan 6, 2017
Completion: Oct 6, 2017
NCT04631315
Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery.
Start: Mar 24, 2019
Completion: Jul 21, 2020
NCT04776096
Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment
Start: Mar 10, 2021
Completion: Aug 18, 2022
NCT05857267
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety
Start: Mar 7, 2023
Completion: Nov 4, 2024
Loading map...